Novel insight into etiology, diagnosis and management of primary adrenal insufficiency

Area of Science:

• Pediatric Endocrinology
• Genetics
• Biochemistry

Background:

• Primary adrenal insufficiency (PAI) is a rare childhood disorder characterized by glucocorticoid and potentially mineralocorticoid deficiency.
• The most common cause in children is 21-hydroxylase deficiency, a defect in steroid biosynthesis.
• Other identified causes include complex steroidogenic defects, metabolic and autoimmune disorders, and adrenal dysgenesis.

Purpose of the Study:

• To review and highlight recent advancements in understanding the genetic basis of PAI in children.
• To discuss newly identified genetic defects contributing to PAI and isolated familial glucocorticoid deficiency (FGD).
• To explore the role of oxidative stress in PAI pathogenesis.

Main Methods:

• Literature review of recent genetic studies on PAI and FGD.
• Analysis of identified gene mutations in affected pediatric populations.
• Examination of biochemical pathways, including steroidogenesis and oxidative stress response.

Main Results:

• New genetic causes for PAI and FGD have been identified, expanding beyond 21-hydroxylase deficiency.
• Mutations in genes like P450 oxidoreductase, cortisone reductase, and those involved in IMAGe syndrome are implicated.
• Recent findings link mutations in nicotinamide nucleotide transhydrogenase (NNT) and TXNRD2 to FGD, highlighting the adrenal cortex's susceptibility to oxidative stress due to impaired NADPH production.

Conclusions:

• The genetic landscape of pediatric PAI and FGD is complex and continually evolving.
• Oxidative stress emerges as a significant factor in certain forms of PAI/FGD, particularly those involving NNT and TXNRD2 mutations.
• Further research into these genetic defects and their molecular mechanisms is crucial for improved diagnosis and potential therapeutic strategies.